{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Central+Nervous+System+Infectious+Disorder&page=2", "query": { "condition": "Central Nervous System Infectious Disorder", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Central+Nervous+System+Infectious+Disorder&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-22T01:31:40.488Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05586581", "title": "SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "HIV Associated Neurocognitive Disorder", "HIV Dementia", "HIV Encephalitis", "Healthy" ], "interventions": [ { "name": "SV2A PET", "type": "DRUG" }, { "name": "TSPO PET", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 70, "start_date": "2023-05-17", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05586581" }, { "nct_id": "NCT00255047", "title": "Safety and Immune Response of Different Pediatric Combination Vaccines.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diphtheria", "Polio", "Pertussis" ], "interventions": [ { "name": "DAPTACEL®. (DTaP), IPOL®., and ActHIB®.", "type": "BIOLOGICAL" }, { "name": "Pentacel®: DTaP-IPV/Hib combined", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV and ActHIB®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2167, "start_date": "2005-11", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 36, "location_summary": "Tuscaloosa, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 29 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00255047" }, { "nct_id": "NCT02003144", "title": "An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neuromyelitis Optica", "Neuromyelitis Optica Spectrum Disorder" ], "interventions": [ { "name": "eculizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2015-01-12", "completion_date": "2021-07-12", "has_results": true, "last_update_posted_date": "2022-08-23", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 19, "location_summary": "Scottsdale, Arizona • Oceanside, California • Washington D.C., District of Columbia + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02003144" }, { "nct_id": "NCT02479698", "title": "Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acquired Immunodeficiency Syndrome", "BK Virus Infection", "Human Immunodeficiency Virus", "JC Virus Infection", "Malignant Neoplasm", "Merkel Cell Carcinoma", "Merkel Cell Polyomavirus Infection", "Viral Encephalitis" ], "interventions": [ { "name": "Allogeneic BK-specific Cytotoxic T-lymphocytes", "type": "BIOLOGICAL" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 100, "start_date": "2015-07-23", "completion_date": "2027-07-31", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02479698" }, { "nct_id": "NCT02096263", "title": "Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Poliomyelitis", "Diphtheria", "Haemophilus Influenzae Type b", "Tetanus", "Acellular Pertussis", "Hepatitis B" ], "interventions": [ { "name": "Infanrix hexa", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pentacel", "type": "BIOLOGICAL" }, { "name": "Engerix-B", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevnar13", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 585, "start_date": "2014-04-16", "completion_date": "2015-11-13", "has_results": true, "last_update_posted_date": "2019-11-27", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 43, "location_summary": "Tucson, Arizona • Fayetteville, Arkansas • Anaheim, California + 38 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Daly City", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02096263" }, { "nct_id": "NCT01984983", "title": "Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Venezuelan Equine Encephalitis Virus Infection" ], "interventions": [ { "name": "Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate", "type": "BIOLOGICAL" }, { "name": "0.9% saline placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Ichor Medical Systems Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 42, "start_date": "2013-12", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2015-08-26", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01984983" }, { "nct_id": "NCT00718666", "title": "The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "Meningococcal vaccine GSK134612", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "2 Years to 6 Years" }, "enrollment_count": 387, "start_date": "2008-10-20", "completion_date": "2014-03-28", "has_results": true, "last_update_posted_date": "2019-06-26", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 14, "location_summary": "Benton, Arkansas • Little Rock, Arkansas • Antioch, California + 10 more", "locations": [ { "city": "Benton", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Antioch", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Hayward", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00718666" }, { "nct_id": "NCT05464251", "title": "Prospective Analysis of Spinal Epidural Abscess", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinal Epidural Abscess" ], "interventions": [ { "name": "Prospective chart review of subjects diagnosed with spinal epidural abscess", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Francis Farhadi", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2022-07-12", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT05464251" }, { "nct_id": "NCT04564495", "title": "Home Based Tele-exercise for People With Chronic Neurological Impairments", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neurologic Disorder", "Stroke", "Spinal Cord Injuries", "Cerebral Palsy", "Hemiplegia", "Hemiparesis", "Multiple Sclerosis", "Parkinson Disease", "Trauma, Brain", "Transverse Myelitis", "Friedreich Ataxia" ], "interventions": [ { "name": "Seated exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Burke Medical Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2021-01-22", "completion_date": "2025-05-31", "has_results": false, "last_update_posted_date": "2025-02-05", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 1, "location_summary": "White Plains, New York", "locations": [ { "city": "White Plains", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04564495" }, { "nct_id": "NCT00232141", "title": "Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections", "Peripheral Neuropathy" ], "interventions": [ { "name": "pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 302, "start_date": "2005-10", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2021-02-09", "last_synced_at": "2026-07-22T01:31:40.488Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00232141" } ] }